NewsBenzinga트라이젬엑스 바이오, TCGX 인수합병 통해 나스닥 상장 계획···합병 완료 시 약 2억 4600만 달러의 총 수익 예상 트라이젬엑스 바이오, TCGX 인수합병 통해 나스닥 상장 계획···합병 완료 시 약 2억 4600만 달러의 총 수익 예상 Benzinga 2026.10.19 11:07 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on PENN Entertainment, Lowers Price Target to $22 HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target Alphabet Stock Rises: What's Going On? $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today Wells Fargo Maintains Equal-Weight on MGM Resorts International, Lowers Price Target to $29 Mark Cuban Says Your Health Insurance Is More Likely To Get You Fired Than Al — It Costs Your Boss $30K
Mark Cuban Says Your Health Insurance Is More Likely To Get You Fired Than Al — It Costs Your Boss $30K
